In this issue:
Global prevalence and burden of OSA
Postoperative CV events in patients with unrecognised OSA
OSA, and CPAP treatment, and CV events in patients with ACS
Symptom subtypes of OSA predict CV outcomes
Sleep duration/quality and napping, and stroke risk
Short sleep duration and AF risk
Nocturnal symptoms perceived as asthma are associated with OSA risk
Impaired sleep quality is associated with COPD exacerbations
Artificial light exposure during sleep increases obesity risk in women
Predicting sleep stage with a consumer wearable device
Atomoxetine + oxybutynin reduces OSA severity
Treatment of OSA with CPAP decreases perceived age
Please login below to download this issue (PDF)